Sanford Research   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Sioux Falls ND United States (1998)

Organization Overview

First Clinical Trial
2007
NCT00688961
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Sanford Research

Active Ingredients

Drugs in Phase 4 Trials (6)

Key: Sanford Research (0) Acquired (6)

bupropion (wellbutrin) (1 trial)

buspirone (buspar) (1 trial)

grapefruit juice (1 trial)

lisdexamfetamine (vyvanse) (1 trial)

topiramate (topamax) (1 trial)

venlafaxine (effexor) (1 trial)

Drugs in Phase 3 Trials (3)

Key: Sanford Research (0) Acquired (3)

duloxetine (Cymbalta) (1 trial)

pramipexole (mirapex) (1 trial)

sertraline (zoloft) (1 trial)

Drugs in Phase 2 Trials (1)

icosapent ethyl (vascepa) (2 trials)

Drugs in Phase 1 Trials (3)

acetylsalicylic acid (aspirin) (1 trial)

cisplatin (platinol) (1 trial)

pembrolizumab (keytruda) (1 trial)

Drugs in Other Trials (3)

Key: Sanford Research (0) Acquired (3)

ethanol (1 trial)

modafinil (provigil) (1 trial)

olanzapine (zyprexa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 1)

Carcinoma, Squamous Cell (Phase 1)

Hypertriglyceridemia (Phase 2)

Laryngeal Neoplasms (Phase 1)

Mouth Neoplasms (Phase 1)

Oropharyngeal Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 13
  • # of Trial APIs: 16